secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytek Biosciences, Inc. (CTKB)
CIK:        0001831915
Form:       8-K
Filed at:   2024-09-12T23:59:59+00:00
Accession:  0001193125-24-217558
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cytek Biosciences COO Paul Christopher Williams resigns effective Sept 27, 2024
-------------------------------------------------------------------------------

- COO Paul Christopher Williams resigned on Sept 9, 2024, effective Sept 27, 2024, to pursue another career opportunity.
- No replacement has been named; CEO Wenbin Jiang remains in charge.
- Resignation is voluntary and not due to any disagreement with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831915/000119312524217558/0001193125-24-217558-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831915/000119312524217558/d891638d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-217558

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer